Global PSMA Imaging Agent for Prostate Cancer Supply, Demand and Key Producers, 2026-2032
The global PSMA Imaging Agent for Prostate Cancer market size is expected to reach $ 2915 million by 2032, rising at a market growth of 6.9% CAGR during the forecast period (2026-2032).
In 2025, the global production of PSMA imaging agent for prostate cancer reached 3.5394 million units, with an average selling price of $500 per unit. The annual production capacity of PSMA imaging agents for prostate cancer worldwide is approximately 5 million units, with a gross margin of about 30.4%. PSMA imaging agent for prostate cancer is a radiotracer that targets prostate?specific membrane antigen (PSMA) and enables molecular?level imaging of prostate cancer lesions via positron emission tomography (PET). PSMA is highly expressed on the surface of prostate cancer cells. After the imaging agent specifically binds to it, PET/CT or PET/MRI equipment is used to detect radioactive signals, thereby enabling high?sensitivity localization of primary lesions, detection of metastases, and assessment of recurrence. It is currently an important tool in precision diagnosis and treatment of prostate cancer. The upstream of PSMA imaging agents for prostate cancer includes radionuclides (such as gallium?68, fluorine?18, etc.), PSMA?targeting ligands (small molecules/peptides/antibodies), and nanocarriers/chelators, among others. The midstream consists of manufacturers of PSMA imaging agents for prostate cancer, while the downstream is mainly used in nuclear medicine and molecular imaging, precision tumor diagnosis, and radiopharmaceuticals and nuclear medicine.
Currently, the market for PSMA imaging agent for prostate cancer is in a phase of rapid development. As a revolutionary molecular imaging tool, it has been widely integrated into clinical management pathways for prostate cancer, playing a key role especially in initial staging, detection of biochemical recurrence, and formulation of treatment strategies. With the growing availability of PET/CT and PET/MRI equipment and the continuous emergence of novel PSMA ligands, the clinical applications of this imaging agent are steadily expanding. Meanwhile, the rise of the theranostics concept means that PSMA imaging agents for prostate cancer are not only used for diagnosis but are also beginning to be linked with PSMA?targeted radionuclide therapy, ushering prostate cancer into a new era of precision medicine. Furthermore, improvements in regulatory approval and standardized production requirements for radiopharmaceuticals, along with gradual optimization of reimbursement policies, have further contributed to the maturation and growth of this market.
Report Scope
This report studies the global PSMA Imaging Agent for Prostate Cancer production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PSMA Imaging Agent for Prostate Cancer and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of PSMA Imaging Agent for Prostate Cancer that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PSMA Imaging Agent for Prostate Cancer total production and demand, 2021-2032, (K Units)
Global PSMA Imaging Agent for Prostate Cancer total production value, 2021-2032, (USD Million)
Global PSMA Imaging Agent for Prostate Cancer production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global PSMA Imaging Agent for Prostate Cancer consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: PSMA Imaging Agent for Prostate Cancer domestic production, consumption, key domestic manufacturers and share
Global PSMA Imaging Agent for Prostate Cancer production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global PSMA Imaging Agent for Prostate Cancer production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global PSMA Imaging Agent for Prostate Cancer production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global PSMA Imaging Agent for Prostate Cancer market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lantheus, Telix Pharmaceuticals, Novartis, Blue Earth Diagnostics?Bracco?, Sinotau, DC PHARMA, Clarity Pharmaceuticals, Hengrui Pharma, CRAND PHARMACEUTICAL, Norroy Bioscience, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PSMA Imaging Agent for Prostate Cancer market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global PSMA Imaging Agent for Prostate Cancer Market, By Region:
1. How big is the global PSMA Imaging Agent for Prostate Cancer market?
2. What is the demand of the global PSMA Imaging Agent for Prostate Cancer market?
3. What is the year over year growth of the global PSMA Imaging Agent for Prostate Cancer market?
4. What is the production and production value of the global PSMA Imaging Agent for Prostate Cancer market?
5. Who are the key producers in the global PSMA Imaging Agent for Prostate Cancer market?
6. What are the growth factors driving the market demand?
In 2025, the global production of PSMA imaging agent for prostate cancer reached 3.5394 million units, with an average selling price of $500 per unit. The annual production capacity of PSMA imaging agents for prostate cancer worldwide is approximately 5 million units, with a gross margin of about 30.4%. PSMA imaging agent for prostate cancer is a radiotracer that targets prostate?specific membrane antigen (PSMA) and enables molecular?level imaging of prostate cancer lesions via positron emission tomography (PET). PSMA is highly expressed on the surface of prostate cancer cells. After the imaging agent specifically binds to it, PET/CT or PET/MRI equipment is used to detect radioactive signals, thereby enabling high?sensitivity localization of primary lesions, detection of metastases, and assessment of recurrence. It is currently an important tool in precision diagnosis and treatment of prostate cancer. The upstream of PSMA imaging agents for prostate cancer includes radionuclides (such as gallium?68, fluorine?18, etc.), PSMA?targeting ligands (small molecules/peptides/antibodies), and nanocarriers/chelators, among others. The midstream consists of manufacturers of PSMA imaging agents for prostate cancer, while the downstream is mainly used in nuclear medicine and molecular imaging, precision tumor diagnosis, and radiopharmaceuticals and nuclear medicine.
Currently, the market for PSMA imaging agent for prostate cancer is in a phase of rapid development. As a revolutionary molecular imaging tool, it has been widely integrated into clinical management pathways for prostate cancer, playing a key role especially in initial staging, detection of biochemical recurrence, and formulation of treatment strategies. With the growing availability of PET/CT and PET/MRI equipment and the continuous emergence of novel PSMA ligands, the clinical applications of this imaging agent are steadily expanding. Meanwhile, the rise of the theranostics concept means that PSMA imaging agents for prostate cancer are not only used for diagnosis but are also beginning to be linked with PSMA?targeted radionuclide therapy, ushering prostate cancer into a new era of precision medicine. Furthermore, improvements in regulatory approval and standardized production requirements for radiopharmaceuticals, along with gradual optimization of reimbursement policies, have further contributed to the maturation and growth of this market.
Report Scope
This report studies the global PSMA Imaging Agent for Prostate Cancer production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PSMA Imaging Agent for Prostate Cancer and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of PSMA Imaging Agent for Prostate Cancer that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global PSMA Imaging Agent for Prostate Cancer total production and demand, 2021-2032, (K Units)
Global PSMA Imaging Agent for Prostate Cancer total production value, 2021-2032, (USD Million)
Global PSMA Imaging Agent for Prostate Cancer production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global PSMA Imaging Agent for Prostate Cancer consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: PSMA Imaging Agent for Prostate Cancer domestic production, consumption, key domestic manufacturers and share
Global PSMA Imaging Agent for Prostate Cancer production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global PSMA Imaging Agent for Prostate Cancer production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global PSMA Imaging Agent for Prostate Cancer production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global PSMA Imaging Agent for Prostate Cancer market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lantheus, Telix Pharmaceuticals, Novartis, Blue Earth Diagnostics?Bracco?, Sinotau, DC PHARMA, Clarity Pharmaceuticals, Hengrui Pharma, CRAND PHARMACEUTICAL, Norroy Bioscience, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PSMA Imaging Agent for Prostate Cancer market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global PSMA Imaging Agent for Prostate Cancer Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 68Ga
- 18F
- First Generation
- Second Generation
- Active Targeting
- Passive Targeting
- Nuclear Medicine and Molecular Imaging
- Precision Oncology Diagnostics
- Radiopharmaceuticals and Radiopharmaceuticals
- Lantheus
- Telix Pharmaceuticals
- Novartis
- Blue Earth Diagnostics?Bracco?
- Sinotau
- DC PHARMA
- Clarity Pharmaceuticals
- Hengrui Pharma
- CRAND PHARMACEUTICAL
- Norroy Bioscience
- HUAYI RADIOPHARMACEUTICALS
- Yunhe Pharma
- C Ray Therapeutics
- Curium Holding France S.A.S.
- ABX advanced biochemical compounds GmbH
- Isotopia Molecular Imaging Ltd.
1. How big is the global PSMA Imaging Agent for Prostate Cancer market?
2. What is the demand of the global PSMA Imaging Agent for Prostate Cancer market?
3. What is the year over year growth of the global PSMA Imaging Agent for Prostate Cancer market?
4. What is the production and production value of the global PSMA Imaging Agent for Prostate Cancer market?
5. Who are the key producers in the global PSMA Imaging Agent for Prostate Cancer market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 PSMA Imaging Agent for Prostate Cancer Introduction
1.2 World PSMA Imaging Agent for Prostate Cancer Supply & Forecast
1.2.1 World PSMA Imaging Agent for Prostate Cancer Production Value (2021 & 2025 & 2032)
1.2.2 World PSMA Imaging Agent for Prostate Cancer Production (2021-2032)
1.2.3 World PSMA Imaging Agent for Prostate Cancer Pricing Trends (2021-2032)
1.3 World PSMA Imaging Agent for Prostate Cancer Production by Region (Based on Production Site)
1.3.1 World PSMA Imaging Agent for Prostate Cancer Production Value by Region (2021-2032)
1.3.2 World PSMA Imaging Agent for Prostate Cancer Production by Region (2021-2032)
1.3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Region (2021-2032)
1.3.4 North America PSMA Imaging Agent for Prostate Cancer Production (2021-2032)
1.3.5 Europe PSMA Imaging Agent for Prostate Cancer Production (2021-2032)
1.3.6 China PSMA Imaging Agent for Prostate Cancer Production (2021-2032)
1.3.7 Japan PSMA Imaging Agent for Prostate Cancer Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 PSMA Imaging Agent for Prostate Cancer Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PSMA Imaging Agent for Prostate Cancer Major Market Trends
2 DEMAND SUMMARY
2.1 World PSMA Imaging Agent for Prostate Cancer Demand (2021-2032)
2.2 World PSMA Imaging Agent for Prostate Cancer Consumption by Region
2.2.1 World PSMA Imaging Agent for Prostate Cancer Consumption by Region (2021-2026)
2.2.2 World PSMA Imaging Agent for Prostate Cancer Consumption Forecast by Region (2027-2032)
2.3 United States PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.4 China PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.5 Europe PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.6 Japan PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.7 South Korea PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.8 ASEAN PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.9 India PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PSMA Imaging Agent for Prostate Cancer Production Value by Manufacturer (2021-2026)
3.2 World PSMA Imaging Agent for Prostate Cancer Production by Manufacturer (2021-2026)
3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Manufacturer (2021-2026)
3.4 PSMA Imaging Agent for Prostate Cancer Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PSMA Imaging Agent for Prostate Cancer Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PSMA Imaging Agent for Prostate Cancer in 2025
3.5.3 Global Concentration Ratios (CR8) for PSMA Imaging Agent for Prostate Cancer in 2025
3.6 PSMA Imaging Agent for Prostate Cancer Market: Overall Company Footprint Analysis
3.6.1 PSMA Imaging Agent for Prostate Cancer Market: Region Footprint
3.6.2 PSMA Imaging Agent for Prostate Cancer Market: Company Product Type Footprint
3.6.3 PSMA Imaging Agent for Prostate Cancer Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Value Comparison
4.1.1 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Comparison
4.2.1 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: PSMA Imaging Agent for Prostate Cancer Consumption Comparison
4.3.1 United States VS China: PSMA Imaging Agent for Prostate Cancer Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: PSMA Imaging Agent for Prostate Cancer Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based PSMA Imaging Agent for Prostate Cancer Manufacturers and Market Share, 2021-2026
4.4.1 United States Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value (2021-2026)
4.4.3 United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production (2021-2026)
4.5 China Based PSMA Imaging Agent for Prostate Cancer Manufacturers and Market Share
4.5.1 China Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value (2021-2026)
4.5.3 China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production (2021-2026)
4.6 Rest of World Based PSMA Imaging Agent for Prostate Cancer Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World PSMA Imaging Agent for Prostate Cancer Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 68Ga
5.2.2 18F
5.3 Market Segment by Type
5.3.1 World PSMA Imaging Agent for Prostate Cancer Production by Type (2021-2032)
5.3.2 World PSMA Imaging Agent for Prostate Cancer Production Value by Type (2021-2032)
5.3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CORE CARRIER MATERIALS
6.1 World PSMA Imaging Agent for Prostate Cancer Market Size Overview by Core Carrier Materials: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Core Carrier Materials
6.2.1 First Generation
6.2.2 Second Generation
6.3 Market Segment by Core Carrier Materials
6.3.1 World PSMA Imaging Agent for Prostate Cancer Production by Core Carrier Materials (2021-2032)
6.3.2 World PSMA Imaging Agent for Prostate Cancer Production Value by Core Carrier Materials (2021-2032)
6.3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Core Carrier Materials (2021-2032)
7 MARKET ANALYSIS BY MECHANISM OF ACTION
7.1 World PSMA Imaging Agent for Prostate Cancer Market Size Overview by Mechanism of Action: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Mechanism of Action
7.2.1 Active Targeting
7.2.2 Passive Targeting
7.3 Market Segment by Mechanism of Action
7.3.1 World PSMA Imaging Agent for Prostate Cancer Production by Mechanism of Action (2021-2032)
7.3.2 World PSMA Imaging Agent for Prostate Cancer Production Value by Mechanism of Action (2021-2032)
7.3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Mechanism of Action (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World PSMA Imaging Agent for Prostate Cancer Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Nuclear Medicine and Molecular Imaging
8.2.2 Precision Oncology Diagnostics
8.2.3 Radiopharmaceuticals and Radiopharmaceuticals
8.3 Market Segment by Application
8.3.1 World PSMA Imaging Agent for Prostate Cancer Production by Application (2021-2032)
8.3.2 World PSMA Imaging Agent for Prostate Cancer Production Value by Application (2021-2032)
8.3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Lantheus
9.1.1 Lantheus Details
9.1.2 Lantheus Major Business
9.1.3 Lantheus PSMA Imaging Agent for Prostate Cancer Product and Services
9.1.4 Lantheus PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Lantheus Recent Developments/Updates
9.1.6 Lantheus Competitive Strengths & Weaknesses
9.2 Telix Pharmaceuticals
9.2.1 Telix Pharmaceuticals Details
9.2.2 Telix Pharmaceuticals Major Business
9.2.3 Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
9.2.4 Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Telix Pharmaceuticals Recent Developments/Updates
9.2.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
9.3 Novartis
9.3.1 Novartis Details
9.3.2 Novartis Major Business
9.3.3 Novartis PSMA Imaging Agent for Prostate Cancer Product and Services
9.3.4 Novartis PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Novartis Recent Developments/Updates
9.3.6 Novartis Competitive Strengths & Weaknesses
9.4 Blue Earth Diagnostics?Bracco?
9.4.1 Blue Earth Diagnostics?Bracco? Details
9.4.2 Blue Earth Diagnostics?Bracco? Major Business
9.4.3 Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Product and Services
9.4.4 Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Blue Earth Diagnostics?Bracco? Recent Developments/Updates
9.4.6 Blue Earth Diagnostics?Bracco? Competitive Strengths & Weaknesses
9.5 Sinotau
9.5.1 Sinotau Details
9.5.2 Sinotau Major Business
9.5.3 Sinotau PSMA Imaging Agent for Prostate Cancer Product and Services
9.5.4 Sinotau PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Sinotau Recent Developments/Updates
9.5.6 Sinotau Competitive Strengths & Weaknesses
9.6 DC PHARMA
9.6.1 DC PHARMA Details
9.6.2 DC PHARMA Major Business
9.6.3 DC PHARMA PSMA Imaging Agent for Prostate Cancer Product and Services
9.6.4 DC PHARMA PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 DC PHARMA Recent Developments/Updates
9.6.6 DC PHARMA Competitive Strengths & Weaknesses
9.7 Clarity Pharmaceuticals
9.7.1 Clarity Pharmaceuticals Details
9.7.2 Clarity Pharmaceuticals Major Business
9.7.3 Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
9.7.4 Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Clarity Pharmaceuticals Recent Developments/Updates
9.7.6 Clarity Pharmaceuticals Competitive Strengths & Weaknesses
9.8 Hengrui Pharma
9.8.1 Hengrui Pharma Details
9.8.2 Hengrui Pharma Major Business
9.8.3 Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
9.8.4 Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Hengrui Pharma Recent Developments/Updates
9.8.6 Hengrui Pharma Competitive Strengths & Weaknesses
9.9 CRAND PHARMACEUTICAL
9.9.1 CRAND PHARMACEUTICAL Details
9.9.2 CRAND PHARMACEUTICAL Major Business
9.9.3 CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Product and Services
9.9.4 CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 CRAND PHARMACEUTICAL Recent Developments/Updates
9.9.6 CRAND PHARMACEUTICAL Competitive Strengths & Weaknesses
9.10 Norroy Bioscience
9.10.1 Norroy Bioscience Details
9.10.2 Norroy Bioscience Major Business
9.10.3 Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Product and Services
9.10.4 Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Norroy Bioscience Recent Developments/Updates
9.10.6 Norroy Bioscience Competitive Strengths & Weaknesses
9.11 HUAYI RADIOPHARMACEUTICALS
9.11.1 HUAYI RADIOPHARMACEUTICALS Details
9.11.2 HUAYI RADIOPHARMACEUTICALS Major Business
9.11.3 HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Product and Services
9.11.4 HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 HUAYI RADIOPHARMACEUTICALS Recent Developments/Updates
9.11.6 HUAYI RADIOPHARMACEUTICALS Competitive Strengths & Weaknesses
9.12 Yunhe Pharma
9.12.1 Yunhe Pharma Details
9.12.2 Yunhe Pharma Major Business
9.12.3 Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
9.12.4 Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Yunhe Pharma Recent Developments/Updates
9.12.6 Yunhe Pharma Competitive Strengths & Weaknesses
9.13 C Ray Therapeutics
9.13.1 C Ray Therapeutics Details
9.13.2 C Ray Therapeutics Major Business
9.13.3 C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Product and Services
9.13.4 C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 C Ray Therapeutics Recent Developments/Updates
9.13.6 C Ray Therapeutics Competitive Strengths & Weaknesses
9.14 Curium Holding France S.A.S.
9.14.1 Curium Holding France S.A.S. Details
9.14.2 Curium Holding France S.A.S. Major Business
9.14.3 Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Product and Services
9.14.4 Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Curium Holding France S.A.S. Recent Developments/Updates
9.14.6 Curium Holding France S.A.S. Competitive Strengths & Weaknesses
9.15 ABX advanced biochemical compounds GmbH
9.15.1 ABX advanced biochemical compounds GmbH Details
9.15.2 ABX advanced biochemical compounds GmbH Major Business
9.15.3 ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Product and Services
9.15.4 ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 ABX advanced biochemical compounds GmbH Recent Developments/Updates
9.15.6 ABX advanced biochemical compounds GmbH Competitive Strengths & Weaknesses
9.16 Isotopia Molecular Imaging Ltd.
9.16.1 Isotopia Molecular Imaging Ltd. Details
9.16.2 Isotopia Molecular Imaging Ltd. Major Business
9.16.3 Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Product and Services
9.16.4 Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Isotopia Molecular Imaging Ltd. Recent Developments/Updates
9.16.6 Isotopia Molecular Imaging Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 PSMA Imaging Agent for Prostate Cancer Industry Chain
10.2 PSMA Imaging Agent for Prostate Cancer Upstream Analysis
10.2.1 PSMA Imaging Agent for Prostate Cancer Core Raw Materials
10.2.2 Main Manufacturers of PSMA Imaging Agent for Prostate Cancer Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 PSMA Imaging Agent for Prostate Cancer Production Mode
10.6 PSMA Imaging Agent for Prostate Cancer Procurement Model
10.7 PSMA Imaging Agent for Prostate Cancer Industry Sales Model and Sales Channels
10.7.1 PSMA Imaging Agent for Prostate Cancer Sales Model
10.7.2 PSMA Imaging Agent for Prostate Cancer Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 PSMA Imaging Agent for Prostate Cancer Introduction
1.2 World PSMA Imaging Agent for Prostate Cancer Supply & Forecast
1.2.1 World PSMA Imaging Agent for Prostate Cancer Production Value (2021 & 2025 & 2032)
1.2.2 World PSMA Imaging Agent for Prostate Cancer Production (2021-2032)
1.2.3 World PSMA Imaging Agent for Prostate Cancer Pricing Trends (2021-2032)
1.3 World PSMA Imaging Agent for Prostate Cancer Production by Region (Based on Production Site)
1.3.1 World PSMA Imaging Agent for Prostate Cancer Production Value by Region (2021-2032)
1.3.2 World PSMA Imaging Agent for Prostate Cancer Production by Region (2021-2032)
1.3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Region (2021-2032)
1.3.4 North America PSMA Imaging Agent for Prostate Cancer Production (2021-2032)
1.3.5 Europe PSMA Imaging Agent for Prostate Cancer Production (2021-2032)
1.3.6 China PSMA Imaging Agent for Prostate Cancer Production (2021-2032)
1.3.7 Japan PSMA Imaging Agent for Prostate Cancer Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 PSMA Imaging Agent for Prostate Cancer Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PSMA Imaging Agent for Prostate Cancer Major Market Trends
2 DEMAND SUMMARY
2.1 World PSMA Imaging Agent for Prostate Cancer Demand (2021-2032)
2.2 World PSMA Imaging Agent for Prostate Cancer Consumption by Region
2.2.1 World PSMA Imaging Agent for Prostate Cancer Consumption by Region (2021-2026)
2.2.2 World PSMA Imaging Agent for Prostate Cancer Consumption Forecast by Region (2027-2032)
2.3 United States PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.4 China PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.5 Europe PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.6 Japan PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.7 South Korea PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.8 ASEAN PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
2.9 India PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PSMA Imaging Agent for Prostate Cancer Production Value by Manufacturer (2021-2026)
3.2 World PSMA Imaging Agent for Prostate Cancer Production by Manufacturer (2021-2026)
3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Manufacturer (2021-2026)
3.4 PSMA Imaging Agent for Prostate Cancer Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PSMA Imaging Agent for Prostate Cancer Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PSMA Imaging Agent for Prostate Cancer in 2025
3.5.3 Global Concentration Ratios (CR8) for PSMA Imaging Agent for Prostate Cancer in 2025
3.6 PSMA Imaging Agent for Prostate Cancer Market: Overall Company Footprint Analysis
3.6.1 PSMA Imaging Agent for Prostate Cancer Market: Region Footprint
3.6.2 PSMA Imaging Agent for Prostate Cancer Market: Company Product Type Footprint
3.6.3 PSMA Imaging Agent for Prostate Cancer Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Value Comparison
4.1.1 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Comparison
4.2.1 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: PSMA Imaging Agent for Prostate Cancer Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: PSMA Imaging Agent for Prostate Cancer Consumption Comparison
4.3.1 United States VS China: PSMA Imaging Agent for Prostate Cancer Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: PSMA Imaging Agent for Prostate Cancer Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based PSMA Imaging Agent for Prostate Cancer Manufacturers and Market Share, 2021-2026
4.4.1 United States Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value (2021-2026)
4.4.3 United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production (2021-2026)
4.5 China Based PSMA Imaging Agent for Prostate Cancer Manufacturers and Market Share
4.5.1 China Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value (2021-2026)
4.5.3 China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production (2021-2026)
4.6 Rest of World Based PSMA Imaging Agent for Prostate Cancer Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World PSMA Imaging Agent for Prostate Cancer Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 68Ga
5.2.2 18F
5.3 Market Segment by Type
5.3.1 World PSMA Imaging Agent for Prostate Cancer Production by Type (2021-2032)
5.3.2 World PSMA Imaging Agent for Prostate Cancer Production Value by Type (2021-2032)
5.3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CORE CARRIER MATERIALS
6.1 World PSMA Imaging Agent for Prostate Cancer Market Size Overview by Core Carrier Materials: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Core Carrier Materials
6.2.1 First Generation
6.2.2 Second Generation
6.3 Market Segment by Core Carrier Materials
6.3.1 World PSMA Imaging Agent for Prostate Cancer Production by Core Carrier Materials (2021-2032)
6.3.2 World PSMA Imaging Agent for Prostate Cancer Production Value by Core Carrier Materials (2021-2032)
6.3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Core Carrier Materials (2021-2032)
7 MARKET ANALYSIS BY MECHANISM OF ACTION
7.1 World PSMA Imaging Agent for Prostate Cancer Market Size Overview by Mechanism of Action: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Mechanism of Action
7.2.1 Active Targeting
7.2.2 Passive Targeting
7.3 Market Segment by Mechanism of Action
7.3.1 World PSMA Imaging Agent for Prostate Cancer Production by Mechanism of Action (2021-2032)
7.3.2 World PSMA Imaging Agent for Prostate Cancer Production Value by Mechanism of Action (2021-2032)
7.3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Mechanism of Action (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World PSMA Imaging Agent for Prostate Cancer Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Nuclear Medicine and Molecular Imaging
8.2.2 Precision Oncology Diagnostics
8.2.3 Radiopharmaceuticals and Radiopharmaceuticals
8.3 Market Segment by Application
8.3.1 World PSMA Imaging Agent for Prostate Cancer Production by Application (2021-2032)
8.3.2 World PSMA Imaging Agent for Prostate Cancer Production Value by Application (2021-2032)
8.3.3 World PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Lantheus
9.1.1 Lantheus Details
9.1.2 Lantheus Major Business
9.1.3 Lantheus PSMA Imaging Agent for Prostate Cancer Product and Services
9.1.4 Lantheus PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Lantheus Recent Developments/Updates
9.1.6 Lantheus Competitive Strengths & Weaknesses
9.2 Telix Pharmaceuticals
9.2.1 Telix Pharmaceuticals Details
9.2.2 Telix Pharmaceuticals Major Business
9.2.3 Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
9.2.4 Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Telix Pharmaceuticals Recent Developments/Updates
9.2.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
9.3 Novartis
9.3.1 Novartis Details
9.3.2 Novartis Major Business
9.3.3 Novartis PSMA Imaging Agent for Prostate Cancer Product and Services
9.3.4 Novartis PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Novartis Recent Developments/Updates
9.3.6 Novartis Competitive Strengths & Weaknesses
9.4 Blue Earth Diagnostics?Bracco?
9.4.1 Blue Earth Diagnostics?Bracco? Details
9.4.2 Blue Earth Diagnostics?Bracco? Major Business
9.4.3 Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Product and Services
9.4.4 Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Blue Earth Diagnostics?Bracco? Recent Developments/Updates
9.4.6 Blue Earth Diagnostics?Bracco? Competitive Strengths & Weaknesses
9.5 Sinotau
9.5.1 Sinotau Details
9.5.2 Sinotau Major Business
9.5.3 Sinotau PSMA Imaging Agent for Prostate Cancer Product and Services
9.5.4 Sinotau PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Sinotau Recent Developments/Updates
9.5.6 Sinotau Competitive Strengths & Weaknesses
9.6 DC PHARMA
9.6.1 DC PHARMA Details
9.6.2 DC PHARMA Major Business
9.6.3 DC PHARMA PSMA Imaging Agent for Prostate Cancer Product and Services
9.6.4 DC PHARMA PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 DC PHARMA Recent Developments/Updates
9.6.6 DC PHARMA Competitive Strengths & Weaknesses
9.7 Clarity Pharmaceuticals
9.7.1 Clarity Pharmaceuticals Details
9.7.2 Clarity Pharmaceuticals Major Business
9.7.3 Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
9.7.4 Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Clarity Pharmaceuticals Recent Developments/Updates
9.7.6 Clarity Pharmaceuticals Competitive Strengths & Weaknesses
9.8 Hengrui Pharma
9.8.1 Hengrui Pharma Details
9.8.2 Hengrui Pharma Major Business
9.8.3 Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
9.8.4 Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Hengrui Pharma Recent Developments/Updates
9.8.6 Hengrui Pharma Competitive Strengths & Weaknesses
9.9 CRAND PHARMACEUTICAL
9.9.1 CRAND PHARMACEUTICAL Details
9.9.2 CRAND PHARMACEUTICAL Major Business
9.9.3 CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Product and Services
9.9.4 CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 CRAND PHARMACEUTICAL Recent Developments/Updates
9.9.6 CRAND PHARMACEUTICAL Competitive Strengths & Weaknesses
9.10 Norroy Bioscience
9.10.1 Norroy Bioscience Details
9.10.2 Norroy Bioscience Major Business
9.10.3 Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Product and Services
9.10.4 Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Norroy Bioscience Recent Developments/Updates
9.10.6 Norroy Bioscience Competitive Strengths & Weaknesses
9.11 HUAYI RADIOPHARMACEUTICALS
9.11.1 HUAYI RADIOPHARMACEUTICALS Details
9.11.2 HUAYI RADIOPHARMACEUTICALS Major Business
9.11.3 HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Product and Services
9.11.4 HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 HUAYI RADIOPHARMACEUTICALS Recent Developments/Updates
9.11.6 HUAYI RADIOPHARMACEUTICALS Competitive Strengths & Weaknesses
9.12 Yunhe Pharma
9.12.1 Yunhe Pharma Details
9.12.2 Yunhe Pharma Major Business
9.12.3 Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
9.12.4 Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Yunhe Pharma Recent Developments/Updates
9.12.6 Yunhe Pharma Competitive Strengths & Weaknesses
9.13 C Ray Therapeutics
9.13.1 C Ray Therapeutics Details
9.13.2 C Ray Therapeutics Major Business
9.13.3 C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Product and Services
9.13.4 C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 C Ray Therapeutics Recent Developments/Updates
9.13.6 C Ray Therapeutics Competitive Strengths & Weaknesses
9.14 Curium Holding France S.A.S.
9.14.1 Curium Holding France S.A.S. Details
9.14.2 Curium Holding France S.A.S. Major Business
9.14.3 Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Product and Services
9.14.4 Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Curium Holding France S.A.S. Recent Developments/Updates
9.14.6 Curium Holding France S.A.S. Competitive Strengths & Weaknesses
9.15 ABX advanced biochemical compounds GmbH
9.15.1 ABX advanced biochemical compounds GmbH Details
9.15.2 ABX advanced biochemical compounds GmbH Major Business
9.15.3 ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Product and Services
9.15.4 ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 ABX advanced biochemical compounds GmbH Recent Developments/Updates
9.15.6 ABX advanced biochemical compounds GmbH Competitive Strengths & Weaknesses
9.16 Isotopia Molecular Imaging Ltd.
9.16.1 Isotopia Molecular Imaging Ltd. Details
9.16.2 Isotopia Molecular Imaging Ltd. Major Business
9.16.3 Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Product and Services
9.16.4 Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Isotopia Molecular Imaging Ltd. Recent Developments/Updates
9.16.6 Isotopia Molecular Imaging Ltd. Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 PSMA Imaging Agent for Prostate Cancer Industry Chain
10.2 PSMA Imaging Agent for Prostate Cancer Upstream Analysis
10.2.1 PSMA Imaging Agent for Prostate Cancer Core Raw Materials
10.2.2 Main Manufacturers of PSMA Imaging Agent for Prostate Cancer Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 PSMA Imaging Agent for Prostate Cancer Production Mode
10.6 PSMA Imaging Agent for Prostate Cancer Procurement Model
10.7 PSMA Imaging Agent for Prostate Cancer Industry Sales Model and Sales Channels
10.7.1 PSMA Imaging Agent for Prostate Cancer Sales Model
10.7.2 PSMA Imaging Agent for Prostate Cancer Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World PSMA Imaging Agent for Prostate Cancer Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World PSMA Imaging Agent for Prostate Cancer Production Value by Region (2021-2026) & (USD Million)
Table 3. World PSMA Imaging Agent for Prostate Cancer Production Value by Region (2027-2032) & (USD Million)
Table 4. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Region (2021-2026)
Table 5. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Region (2027-2032)
Table 6. World PSMA Imaging Agent for Prostate Cancer Production by Region (2021-2026) & (K Units)
Table 7. World PSMA Imaging Agent for Prostate Cancer Production by Region (2027-2032) & (K Units)
Table 8. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Region (2021-2026)
Table 9. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Region (2027-2032)
Table 10. World PSMA Imaging Agent for Prostate Cancer Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World PSMA Imaging Agent for Prostate Cancer Average Price by Region (2027-2032) & (US$/Unit)
Table 12. PSMA Imaging Agent for Prostate Cancer Major Market Trends
Table 13. World PSMA Imaging Agent for Prostate Cancer Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World PSMA Imaging Agent for Prostate Cancer Consumption by Region (2021-2026) & (K Units)
Table 15. World PSMA Imaging Agent for Prostate Cancer Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World PSMA Imaging Agent for Prostate Cancer Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key PSMA Imaging Agent for Prostate Cancer Producers in 2025
Table 18. World PSMA Imaging Agent for Prostate Cancer Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key PSMA Imaging Agent for Prostate Cancer Producers in 2025
Table 20. World PSMA Imaging Agent for Prostate Cancer Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global PSMA Imaging Agent for Prostate Cancer Company Evaluation Quadrant
Table 22. World PSMA Imaging Agent for Prostate Cancer Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and PSMA Imaging Agent for Prostate Cancer Production Site of Key Manufacturer
Table 24. PSMA Imaging Agent for Prostate Cancer Market: Company Product Type Footprint
Table 25. PSMA Imaging Agent for Prostate Cancer Market: Company Product Application Footprint
Table 26. PSMA Imaging Agent for Prostate Cancer Competitive Factors
Table 27. PSMA Imaging Agent for Prostate Cancer New Entrant and Capacity Expansion Plans
Table 28. PSMA Imaging Agent for Prostate Cancer Mergers & Acquisitions Activity
Table 29. United States VS China PSMA Imaging Agent for Prostate Cancer Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China PSMA Imaging Agent for Prostate Cancer Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China PSMA Imaging Agent for Prostate Cancer Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share (2021-2026)
Table 37. China Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share (2021-2026)
Table 42. Rest of World Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share (2021-2026)
Table 47. World PSMA Imaging Agent for Prostate Cancer Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World PSMA Imaging Agent for Prostate Cancer Production by Type (2021-2026) & (K Units)
Table 49. World PSMA Imaging Agent for Prostate Cancer Production by Type (2027-2032) & (K Units)
Table 50. World PSMA Imaging Agent for Prostate Cancer Production Value by Type (2021-2026) & (USD Million)
Table 51. World PSMA Imaging Agent for Prostate Cancer Production Value by Type (2027-2032) & (USD Million)
Table 52. World PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World PSMA Imaging Agent for Prostate Cancer Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World PSMA Imaging Agent for Prostate Cancer Production Value by Core Carrier Materials, (USD Million), 2021 & 2025 & 2032
Table 55. World PSMA Imaging Agent for Prostate Cancer Production by Core Carrier Materials (2021-2026) & (K Units)
Table 56. World PSMA Imaging Agent for Prostate Cancer Production by Core Carrier Materials (2027-2032) & (K Units)
Table 57. World PSMA Imaging Agent for Prostate Cancer Production Value by Core Carrier Materials (2021-2026) & (USD Million)
Table 58. World PSMA Imaging Agent for Prostate Cancer Production Value by Core Carrier Materials (2027-2032) & (USD Million)
Table 59. World PSMA Imaging Agent for Prostate Cancer Average Price by Core Carrier Materials (2021-2026) & (US$/Unit)
Table 60. World PSMA Imaging Agent for Prostate Cancer Average Price by Core Carrier Materials (2027-2032) & (US$/Unit)
Table 61. World PSMA Imaging Agent for Prostate Cancer Production Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Table 62. World PSMA Imaging Agent for Prostate Cancer Production by Mechanism of Action (2021-2026) & (K Units)
Table 63. World PSMA Imaging Agent for Prostate Cancer Production by Mechanism of Action (2027-2032) & (K Units)
Table 64. World PSMA Imaging Agent for Prostate Cancer Production Value by Mechanism of Action (2021-2026) & (USD Million)
Table 65. World PSMA Imaging Agent for Prostate Cancer Production Value by Mechanism of Action (2027-2032) & (USD Million)
Table 66. World PSMA Imaging Agent for Prostate Cancer Average Price by Mechanism of Action (2021-2026) & (US$/Unit)
Table 67. World PSMA Imaging Agent for Prostate Cancer Average Price by Mechanism of Action (2027-2032) & (US$/Unit)
Table 68. World PSMA Imaging Agent for Prostate Cancer Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World PSMA Imaging Agent for Prostate Cancer Production by Application (2021-2026) & (K Units)
Table 70. World PSMA Imaging Agent for Prostate Cancer Production by Application (2027-2032) & (K Units)
Table 71. World PSMA Imaging Agent for Prostate Cancer Production Value by Application (2021-2026) & (USD Million)
Table 72. World PSMA Imaging Agent for Prostate Cancer Production Value by Application (2027-2032) & (USD Million)
Table 73. World PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World PSMA Imaging Agent for Prostate Cancer Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Lantheus Basic Information, Manufacturing Base and Competitors
Table 76. Lantheus Major Business
Table 77. Lantheus PSMA Imaging Agent for Prostate Cancer Product and Services
Table 78. Lantheus PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Lantheus Recent Developments/Updates
Table 80. Lantheus Competitive Strengths & Weaknesses
Table 81. Telix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 82. Telix Pharmaceuticals Major Business
Table 83. Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
Table 84. Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Telix Pharmaceuticals Recent Developments/Updates
Table 86. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 87. Novartis Basic Information, Manufacturing Base and Competitors
Table 88. Novartis Major Business
Table 89. Novartis PSMA Imaging Agent for Prostate Cancer Product and Services
Table 90. Novartis PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Novartis Recent Developments/Updates
Table 92. Novartis Competitive Strengths & Weaknesses
Table 93. Blue Earth Diagnostics?Bracco? Basic Information, Manufacturing Base and Competitors
Table 94. Blue Earth Diagnostics?Bracco? Major Business
Table 95. Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Product and Services
Table 96. Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Blue Earth Diagnostics?Bracco? Recent Developments/Updates
Table 98. Blue Earth Diagnostics?Bracco? Competitive Strengths & Weaknesses
Table 99. Sinotau Basic Information, Manufacturing Base and Competitors
Table 100. Sinotau Major Business
Table 101. Sinotau PSMA Imaging Agent for Prostate Cancer Product and Services
Table 102. Sinotau PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Sinotau Recent Developments/Updates
Table 104. Sinotau Competitive Strengths & Weaknesses
Table 105. DC PHARMA Basic Information, Manufacturing Base and Competitors
Table 106. DC PHARMA Major Business
Table 107. DC PHARMA PSMA Imaging Agent for Prostate Cancer Product and Services
Table 108. DC PHARMA PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. DC PHARMA Recent Developments/Updates
Table 110. DC PHARMA Competitive Strengths & Weaknesses
Table 111. Clarity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 112. Clarity Pharmaceuticals Major Business
Table 113. Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
Table 114. Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Clarity Pharmaceuticals Recent Developments/Updates
Table 116. Clarity Pharmaceuticals Competitive Strengths & Weaknesses
Table 117. Hengrui Pharma Basic Information, Manufacturing Base and Competitors
Table 118. Hengrui Pharma Major Business
Table 119. Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
Table 120. Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Hengrui Pharma Recent Developments/Updates
Table 122. Hengrui Pharma Competitive Strengths & Weaknesses
Table 123. CRAND PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 124. CRAND PHARMACEUTICAL Major Business
Table 125. CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Product and Services
Table 126. CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. CRAND PHARMACEUTICAL Recent Developments/Updates
Table 128. CRAND PHARMACEUTICAL Competitive Strengths & Weaknesses
Table 129. Norroy Bioscience Basic Information, Manufacturing Base and Competitors
Table 130. Norroy Bioscience Major Business
Table 131. Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Product and Services
Table 132. Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Norroy Bioscience Recent Developments/Updates
Table 134. Norroy Bioscience Competitive Strengths & Weaknesses
Table 135. HUAYI RADIOPHARMACEUTICALS Basic Information, Manufacturing Base and Competitors
Table 136. HUAYI RADIOPHARMACEUTICALS Major Business
Table 137. HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Product and Services
Table 138. HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. HUAYI RADIOPHARMACEUTICALS Recent Developments/Updates
Table 140. HUAYI RADIOPHARMACEUTICALS Competitive Strengths & Weaknesses
Table 141. Yunhe Pharma Basic Information, Manufacturing Base and Competitors
Table 142. Yunhe Pharma Major Business
Table 143. Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
Table 144. Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Yunhe Pharma Recent Developments/Updates
Table 146. Yunhe Pharma Competitive Strengths & Weaknesses
Table 147. C Ray Therapeutics Basic Information, Manufacturing Base and Competitors
Table 148. C Ray Therapeutics Major Business
Table 149. C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Product and Services
Table 150. C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. C Ray Therapeutics Recent Developments/Updates
Table 152. C Ray Therapeutics Competitive Strengths & Weaknesses
Table 153. Curium Holding France S.A.S. Basic Information, Manufacturing Base and Competitors
Table 154. Curium Holding France S.A.S. Major Business
Table 155. Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Product and Services
Table 156. Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Curium Holding France S.A.S. Recent Developments/Updates
Table 158. Curium Holding France S.A.S. Competitive Strengths & Weaknesses
Table 159. ABX advanced biochemical compounds GmbH Basic Information, Manufacturing Base and Competitors
Table 160. ABX advanced biochemical compounds GmbH Major Business
Table 161. ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Product and Services
Table 162. ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. ABX advanced biochemical compounds GmbH Recent Developments/Updates
Table 164. ABX advanced biochemical compounds GmbH Competitive Strengths & Weaknesses
Table 165. Isotopia Molecular Imaging Ltd. Basic Information, Manufacturing Base and Competitors
Table 166. Isotopia Molecular Imaging Ltd. Major Business
Table 167. Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Product and Services
Table 168. Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Isotopia Molecular Imaging Ltd. Recent Developments/Updates
Table 170. Isotopia Molecular Imaging Ltd. Competitive Strengths & Weaknesses
Table 171. Global Key Players of PSMA Imaging Agent for Prostate Cancer Upstream (Raw Materials)
Table 172. Global PSMA Imaging Agent for Prostate Cancer Typical Customers
Table 173. PSMA Imaging Agent for Prostate Cancer Typical Distributors
Table 1. World PSMA Imaging Agent for Prostate Cancer Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World PSMA Imaging Agent for Prostate Cancer Production Value by Region (2021-2026) & (USD Million)
Table 3. World PSMA Imaging Agent for Prostate Cancer Production Value by Region (2027-2032) & (USD Million)
Table 4. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Region (2021-2026)
Table 5. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Region (2027-2032)
Table 6. World PSMA Imaging Agent for Prostate Cancer Production by Region (2021-2026) & (K Units)
Table 7. World PSMA Imaging Agent for Prostate Cancer Production by Region (2027-2032) & (K Units)
Table 8. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Region (2021-2026)
Table 9. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Region (2027-2032)
Table 10. World PSMA Imaging Agent for Prostate Cancer Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World PSMA Imaging Agent for Prostate Cancer Average Price by Region (2027-2032) & (US$/Unit)
Table 12. PSMA Imaging Agent for Prostate Cancer Major Market Trends
Table 13. World PSMA Imaging Agent for Prostate Cancer Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World PSMA Imaging Agent for Prostate Cancer Consumption by Region (2021-2026) & (K Units)
Table 15. World PSMA Imaging Agent for Prostate Cancer Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World PSMA Imaging Agent for Prostate Cancer Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key PSMA Imaging Agent for Prostate Cancer Producers in 2025
Table 18. World PSMA Imaging Agent for Prostate Cancer Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key PSMA Imaging Agent for Prostate Cancer Producers in 2025
Table 20. World PSMA Imaging Agent for Prostate Cancer Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global PSMA Imaging Agent for Prostate Cancer Company Evaluation Quadrant
Table 22. World PSMA Imaging Agent for Prostate Cancer Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and PSMA Imaging Agent for Prostate Cancer Production Site of Key Manufacturer
Table 24. PSMA Imaging Agent for Prostate Cancer Market: Company Product Type Footprint
Table 25. PSMA Imaging Agent for Prostate Cancer Market: Company Product Application Footprint
Table 26. PSMA Imaging Agent for Prostate Cancer Competitive Factors
Table 27. PSMA Imaging Agent for Prostate Cancer New Entrant and Capacity Expansion Plans
Table 28. PSMA Imaging Agent for Prostate Cancer Mergers & Acquisitions Activity
Table 29. United States VS China PSMA Imaging Agent for Prostate Cancer Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China PSMA Imaging Agent for Prostate Cancer Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China PSMA Imaging Agent for Prostate Cancer Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share (2021-2026)
Table 37. China Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share (2021-2026)
Table 42. Rest of World Based PSMA Imaging Agent for Prostate Cancer Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share (2021-2026)
Table 47. World PSMA Imaging Agent for Prostate Cancer Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World PSMA Imaging Agent for Prostate Cancer Production by Type (2021-2026) & (K Units)
Table 49. World PSMA Imaging Agent for Prostate Cancer Production by Type (2027-2032) & (K Units)
Table 50. World PSMA Imaging Agent for Prostate Cancer Production Value by Type (2021-2026) & (USD Million)
Table 51. World PSMA Imaging Agent for Prostate Cancer Production Value by Type (2027-2032) & (USD Million)
Table 52. World PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World PSMA Imaging Agent for Prostate Cancer Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World PSMA Imaging Agent for Prostate Cancer Production Value by Core Carrier Materials, (USD Million), 2021 & 2025 & 2032
Table 55. World PSMA Imaging Agent for Prostate Cancer Production by Core Carrier Materials (2021-2026) & (K Units)
Table 56. World PSMA Imaging Agent for Prostate Cancer Production by Core Carrier Materials (2027-2032) & (K Units)
Table 57. World PSMA Imaging Agent for Prostate Cancer Production Value by Core Carrier Materials (2021-2026) & (USD Million)
Table 58. World PSMA Imaging Agent for Prostate Cancer Production Value by Core Carrier Materials (2027-2032) & (USD Million)
Table 59. World PSMA Imaging Agent for Prostate Cancer Average Price by Core Carrier Materials (2021-2026) & (US$/Unit)
Table 60. World PSMA Imaging Agent for Prostate Cancer Average Price by Core Carrier Materials (2027-2032) & (US$/Unit)
Table 61. World PSMA Imaging Agent for Prostate Cancer Production Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Table 62. World PSMA Imaging Agent for Prostate Cancer Production by Mechanism of Action (2021-2026) & (K Units)
Table 63. World PSMA Imaging Agent for Prostate Cancer Production by Mechanism of Action (2027-2032) & (K Units)
Table 64. World PSMA Imaging Agent for Prostate Cancer Production Value by Mechanism of Action (2021-2026) & (USD Million)
Table 65. World PSMA Imaging Agent for Prostate Cancer Production Value by Mechanism of Action (2027-2032) & (USD Million)
Table 66. World PSMA Imaging Agent for Prostate Cancer Average Price by Mechanism of Action (2021-2026) & (US$/Unit)
Table 67. World PSMA Imaging Agent for Prostate Cancer Average Price by Mechanism of Action (2027-2032) & (US$/Unit)
Table 68. World PSMA Imaging Agent for Prostate Cancer Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World PSMA Imaging Agent for Prostate Cancer Production by Application (2021-2026) & (K Units)
Table 70. World PSMA Imaging Agent for Prostate Cancer Production by Application (2027-2032) & (K Units)
Table 71. World PSMA Imaging Agent for Prostate Cancer Production Value by Application (2021-2026) & (USD Million)
Table 72. World PSMA Imaging Agent for Prostate Cancer Production Value by Application (2027-2032) & (USD Million)
Table 73. World PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World PSMA Imaging Agent for Prostate Cancer Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Lantheus Basic Information, Manufacturing Base and Competitors
Table 76. Lantheus Major Business
Table 77. Lantheus PSMA Imaging Agent for Prostate Cancer Product and Services
Table 78. Lantheus PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Lantheus Recent Developments/Updates
Table 80. Lantheus Competitive Strengths & Weaknesses
Table 81. Telix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 82. Telix Pharmaceuticals Major Business
Table 83. Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
Table 84. Telix Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Telix Pharmaceuticals Recent Developments/Updates
Table 86. Telix Pharmaceuticals Competitive Strengths & Weaknesses
Table 87. Novartis Basic Information, Manufacturing Base and Competitors
Table 88. Novartis Major Business
Table 89. Novartis PSMA Imaging Agent for Prostate Cancer Product and Services
Table 90. Novartis PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Novartis Recent Developments/Updates
Table 92. Novartis Competitive Strengths & Weaknesses
Table 93. Blue Earth Diagnostics?Bracco? Basic Information, Manufacturing Base and Competitors
Table 94. Blue Earth Diagnostics?Bracco? Major Business
Table 95. Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Product and Services
Table 96. Blue Earth Diagnostics?Bracco? PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Blue Earth Diagnostics?Bracco? Recent Developments/Updates
Table 98. Blue Earth Diagnostics?Bracco? Competitive Strengths & Weaknesses
Table 99. Sinotau Basic Information, Manufacturing Base and Competitors
Table 100. Sinotau Major Business
Table 101. Sinotau PSMA Imaging Agent for Prostate Cancer Product and Services
Table 102. Sinotau PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Sinotau Recent Developments/Updates
Table 104. Sinotau Competitive Strengths & Weaknesses
Table 105. DC PHARMA Basic Information, Manufacturing Base and Competitors
Table 106. DC PHARMA Major Business
Table 107. DC PHARMA PSMA Imaging Agent for Prostate Cancer Product and Services
Table 108. DC PHARMA PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. DC PHARMA Recent Developments/Updates
Table 110. DC PHARMA Competitive Strengths & Weaknesses
Table 111. Clarity Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 112. Clarity Pharmaceuticals Major Business
Table 113. Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Product and Services
Table 114. Clarity Pharmaceuticals PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Clarity Pharmaceuticals Recent Developments/Updates
Table 116. Clarity Pharmaceuticals Competitive Strengths & Weaknesses
Table 117. Hengrui Pharma Basic Information, Manufacturing Base and Competitors
Table 118. Hengrui Pharma Major Business
Table 119. Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
Table 120. Hengrui Pharma PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Hengrui Pharma Recent Developments/Updates
Table 122. Hengrui Pharma Competitive Strengths & Weaknesses
Table 123. CRAND PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 124. CRAND PHARMACEUTICAL Major Business
Table 125. CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Product and Services
Table 126. CRAND PHARMACEUTICAL PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. CRAND PHARMACEUTICAL Recent Developments/Updates
Table 128. CRAND PHARMACEUTICAL Competitive Strengths & Weaknesses
Table 129. Norroy Bioscience Basic Information, Manufacturing Base and Competitors
Table 130. Norroy Bioscience Major Business
Table 131. Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Product and Services
Table 132. Norroy Bioscience PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Norroy Bioscience Recent Developments/Updates
Table 134. Norroy Bioscience Competitive Strengths & Weaknesses
Table 135. HUAYI RADIOPHARMACEUTICALS Basic Information, Manufacturing Base and Competitors
Table 136. HUAYI RADIOPHARMACEUTICALS Major Business
Table 137. HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Product and Services
Table 138. HUAYI RADIOPHARMACEUTICALS PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. HUAYI RADIOPHARMACEUTICALS Recent Developments/Updates
Table 140. HUAYI RADIOPHARMACEUTICALS Competitive Strengths & Weaknesses
Table 141. Yunhe Pharma Basic Information, Manufacturing Base and Competitors
Table 142. Yunhe Pharma Major Business
Table 143. Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Product and Services
Table 144. Yunhe Pharma PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Yunhe Pharma Recent Developments/Updates
Table 146. Yunhe Pharma Competitive Strengths & Weaknesses
Table 147. C Ray Therapeutics Basic Information, Manufacturing Base and Competitors
Table 148. C Ray Therapeutics Major Business
Table 149. C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Product and Services
Table 150. C Ray Therapeutics PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. C Ray Therapeutics Recent Developments/Updates
Table 152. C Ray Therapeutics Competitive Strengths & Weaknesses
Table 153. Curium Holding France S.A.S. Basic Information, Manufacturing Base and Competitors
Table 154. Curium Holding France S.A.S. Major Business
Table 155. Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Product and Services
Table 156. Curium Holding France S.A.S. PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Curium Holding France S.A.S. Recent Developments/Updates
Table 158. Curium Holding France S.A.S. Competitive Strengths & Weaknesses
Table 159. ABX advanced biochemical compounds GmbH Basic Information, Manufacturing Base and Competitors
Table 160. ABX advanced biochemical compounds GmbH Major Business
Table 161. ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Product and Services
Table 162. ABX advanced biochemical compounds GmbH PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. ABX advanced biochemical compounds GmbH Recent Developments/Updates
Table 164. ABX advanced biochemical compounds GmbH Competitive Strengths & Weaknesses
Table 165. Isotopia Molecular Imaging Ltd. Basic Information, Manufacturing Base and Competitors
Table 166. Isotopia Molecular Imaging Ltd. Major Business
Table 167. Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Product and Services
Table 168. Isotopia Molecular Imaging Ltd. PSMA Imaging Agent for Prostate Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Isotopia Molecular Imaging Ltd. Recent Developments/Updates
Table 170. Isotopia Molecular Imaging Ltd. Competitive Strengths & Weaknesses
Table 171. Global Key Players of PSMA Imaging Agent for Prostate Cancer Upstream (Raw Materials)
Table 172. Global PSMA Imaging Agent for Prostate Cancer Typical Customers
Table 173. PSMA Imaging Agent for Prostate Cancer Typical Distributors
LIST OF FIGURES
Figure 1. PSMA Imaging Agent for Prostate Cancer Picture
Figure 2. World PSMA Imaging Agent for Prostate Cancer Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World PSMA Imaging Agent for Prostate Cancer Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World PSMA Imaging Agent for Prostate Cancer Production (2021-2032) & (K Units)
Figure 5. World PSMA Imaging Agent for Prostate Cancer Average Price (2021-2032) & (US$/Unit)
Figure 6. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Region (2021-2032)
Figure 7. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Region (2021-2032)
Figure 8. North America PSMA Imaging Agent for Prostate Cancer Production (2021-2032) & (K Units)
Figure 9. Europe PSMA Imaging Agent for Prostate Cancer Production (2021-2032) & (K Units)
Figure 10. China PSMA Imaging Agent for Prostate Cancer Production (2021-2032) & (K Units)
Figure 11. Japan PSMA Imaging Agent for Prostate Cancer Production (2021-2032) & (K Units)
Figure 12. PSMA Imaging Agent for Prostate Cancer Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 15. World PSMA Imaging Agent for Prostate Cancer Consumption Market Share by Region (2021-2032)
Figure 16. United States PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 17. China PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 18. Europe PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 19. Japan PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 20. South Korea PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 21. ASEAN PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 22. India PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of PSMA Imaging Agent for Prostate Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for PSMA Imaging Agent for Prostate Cancer Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for PSMA Imaging Agent for Prostate Cancer Markets in 2025
Figure 26. United States VS China: PSMA Imaging Agent for Prostate Cancer Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: PSMA Imaging Agent for Prostate Cancer Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: PSMA Imaging Agent for Prostate Cancer Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share 2025
Figure 30. China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share 2025
Figure 31. Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share 2025
Figure 32. World PSMA Imaging Agent for Prostate Cancer Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Type in 2025
Figure 34. 68Ga
Figure 35. 18F
Figure 36. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Type (2021-2032)
Figure 37. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Type (2021-2032)
Figure 38. World PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World PSMA Imaging Agent for Prostate Cancer Production Value by Core Carrier Materials, (USD Million), 2021 & 2025 & 2032
Figure 40. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Core Carrier Materials in 2025
Figure 41. First Generation
Figure 42. Second Generation
Figure 43. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Core Carrier Materials (2021-2032)
Figure 44. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Core Carrier Materials (2021-2032)
Figure 45. World PSMA Imaging Agent for Prostate Cancer Average Price by Core Carrier Materials (2021-2032) & (US$/Unit)
Figure 46. World PSMA Imaging Agent for Prostate Cancer Production Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Figure 47. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Mechanism of Action in 2025
Figure 48. Active Targeting
Figure 49. Passive Targeting
Figure 50. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Mechanism of Action (2021-2032)
Figure 51. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Mechanism of Action (2021-2032)
Figure 52. World PSMA Imaging Agent for Prostate Cancer Average Price by Mechanism of Action (2021-2032) & (US$/Unit)
Figure 53. World PSMA Imaging Agent for Prostate Cancer Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Application in 2025
Figure 55. Nuclear Medicine and Molecular Imaging
Figure 56. Precision Oncology Diagnostics
Figure 57. Radiopharmaceuticals and Radiopharmaceuticals
Figure 58. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Application (2021-2032)
Figure 59. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Application (2021-2032)
Figure 60. World PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2032) & (US$/Unit)
Figure 61. PSMA Imaging Agent for Prostate Cancer Industry Chain
Figure 62. PSMA Imaging Agent for Prostate Cancer Procurement Model
Figure 63. PSMA Imaging Agent for Prostate Cancer Sales Model
Figure 64. PSMA Imaging Agent for Prostate Cancer Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
Figure 1. PSMA Imaging Agent for Prostate Cancer Picture
Figure 2. World PSMA Imaging Agent for Prostate Cancer Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World PSMA Imaging Agent for Prostate Cancer Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World PSMA Imaging Agent for Prostate Cancer Production (2021-2032) & (K Units)
Figure 5. World PSMA Imaging Agent for Prostate Cancer Average Price (2021-2032) & (US$/Unit)
Figure 6. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Region (2021-2032)
Figure 7. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Region (2021-2032)
Figure 8. North America PSMA Imaging Agent for Prostate Cancer Production (2021-2032) & (K Units)
Figure 9. Europe PSMA Imaging Agent for Prostate Cancer Production (2021-2032) & (K Units)
Figure 10. China PSMA Imaging Agent for Prostate Cancer Production (2021-2032) & (K Units)
Figure 11. Japan PSMA Imaging Agent for Prostate Cancer Production (2021-2032) & (K Units)
Figure 12. PSMA Imaging Agent for Prostate Cancer Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 15. World PSMA Imaging Agent for Prostate Cancer Consumption Market Share by Region (2021-2032)
Figure 16. United States PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 17. China PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 18. Europe PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 19. Japan PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 20. South Korea PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 21. ASEAN PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 22. India PSMA Imaging Agent for Prostate Cancer Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of PSMA Imaging Agent for Prostate Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for PSMA Imaging Agent for Prostate Cancer Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for PSMA Imaging Agent for Prostate Cancer Markets in 2025
Figure 26. United States VS China: PSMA Imaging Agent for Prostate Cancer Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: PSMA Imaging Agent for Prostate Cancer Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: PSMA Imaging Agent for Prostate Cancer Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share 2025
Figure 30. China Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share 2025
Figure 31. Rest of World Based Manufacturers PSMA Imaging Agent for Prostate Cancer Production Market Share 2025
Figure 32. World PSMA Imaging Agent for Prostate Cancer Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Type in 2025
Figure 34. 68Ga
Figure 35. 18F
Figure 36. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Type (2021-2032)
Figure 37. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Type (2021-2032)
Figure 38. World PSMA Imaging Agent for Prostate Cancer Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World PSMA Imaging Agent for Prostate Cancer Production Value by Core Carrier Materials, (USD Million), 2021 & 2025 & 2032
Figure 40. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Core Carrier Materials in 2025
Figure 41. First Generation
Figure 42. Second Generation
Figure 43. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Core Carrier Materials (2021-2032)
Figure 44. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Core Carrier Materials (2021-2032)
Figure 45. World PSMA Imaging Agent for Prostate Cancer Average Price by Core Carrier Materials (2021-2032) & (US$/Unit)
Figure 46. World PSMA Imaging Agent for Prostate Cancer Production Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Figure 47. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Mechanism of Action in 2025
Figure 48. Active Targeting
Figure 49. Passive Targeting
Figure 50. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Mechanism of Action (2021-2032)
Figure 51. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Mechanism of Action (2021-2032)
Figure 52. World PSMA Imaging Agent for Prostate Cancer Average Price by Mechanism of Action (2021-2032) & (US$/Unit)
Figure 53. World PSMA Imaging Agent for Prostate Cancer Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Application in 2025
Figure 55. Nuclear Medicine and Molecular Imaging
Figure 56. Precision Oncology Diagnostics
Figure 57. Radiopharmaceuticals and Radiopharmaceuticals
Figure 58. World PSMA Imaging Agent for Prostate Cancer Production Market Share by Application (2021-2032)
Figure 59. World PSMA Imaging Agent for Prostate Cancer Production Value Market Share by Application (2021-2032)
Figure 60. World PSMA Imaging Agent for Prostate Cancer Average Price by Application (2021-2032) & (US$/Unit)
Figure 61. PSMA Imaging Agent for Prostate Cancer Industry Chain
Figure 62. PSMA Imaging Agent for Prostate Cancer Procurement Model
Figure 63. PSMA Imaging Agent for Prostate Cancer Sales Model
Figure 64. PSMA Imaging Agent for Prostate Cancer Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
